COVID-19 recombinant spike protein antigen vaccine
RxNorm 2566034
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2566034 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: COVID-19 recombinant spike protein antigen vaccine.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SY
Synonym (SY):
2019 novel coronavirus recombinant spike protein antigen vaccine
(Atom ID: 12664483)
SY
Synonym (SY):
COVID-19 recombinant spike protein antigen vaccine
(Atom ID: 12664761)
PT
Designated preferred name (PT):
SARS-CoV-2 recombinant spike protein antigen vaccine
(Atom ID: 12666231)
SY
Synonym (SY):
Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen only vaccine product
(Atom ID: 12666264)
FN